PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 18, 2004 Subscribe to this News Feed    
 

Research And Markets - Lack Of Necessary Research Resources Can Lead To The Failure Of Pharmaceutical Brand Teams To Complete Their Most Important Tasks

Research and Markets (researchandmarkets.com/reports/c9391) has announced the addition of Pharmaceutical Market Research: Decision Support for Brand Growth to their offering.

(PRWEB) November 18, 2004 -- Market research is such an integral part of the strategic process for pharmaceutical brand teams that few major decisions are made without some support data. At the same time, market research teams often lack the necessary resources to accomplish some of their most important tasks during product development. This study highlights common resource gaps in pharmaceutical market research groups, along with identifying tactics to elevate the strategic impact of this very important function.

Research and Markets (http://www.researchandmarkets.com/reports/c9391) has announced the addition of Pharmaceutical Market Research: Decision Support for Brand Growth to their offering.

The most successful market research teams maintain a keen awareness of industry trends at all times. To truly impact brand strategy, these market research teams get involved from the outset and help position products well ahead of Launch. By combining solid activity planning and adequate resources, market research groups can often be the driving factor in major go/no-go decisions.

Several components contribute to a strong market research plan:
- Structure & Investment -- Average market research spending remained the same over the last three years, but companies have favoured higher early-stage investments.
- Strategy Development -- Market research strategy development begins with overall brand goals. Research groups must function as part of the brand team every step of the way.
- Activity Coordination -- Even companies with low market research budgets can compete with large products if they know how to coordinate their activities.

The companies mentioned in this report are as follows:
- Alcon Labs
- AstraZeneca
- Aventis Pasteur
- Bayer
- Biopedal
- Bristol-Myers Squibb
- Eli Lilly
- EMD Pharmaceuticals
- Merck KGaA
- Schering AG
- Novartis
- Pfizer
- Procter and Gamble Pharmaceuticals
- Roche
- Sanofi-Aventis
- Schering-Plough
- Schwarz Pharma
- Theratechnologies
- Wyeth

For more information visit http://www.researchandmarkets.com/reports/c9391

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Laura Wood
RESEARCH AND MARKETS
35314100862
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.